Overview

Loop Diuretics Administration and Acute Heart Failure

Status:
Completed
Trial end date:
2017-12-28
Target enrollment:
Participant gender:
Summary
Intravenous loop diuretics is the therapy most commonly used to treat pulmonary congestion and systemic fluid overload. In theory, continuous infusion should allow for a more consistent diuresis, avoiding the sodium reabsorption in the distal tubule as well as the neurohormonal activation. This should lead to renal function improvement and BNP decrease.
Phase:
Phase 4
Details
Lead Sponsor:
University of Siena
Treatments:
Diuretics
Furosemide
Sodium Potassium Chloride Symporter Inhibitors